EpiPen (0.3 mg) auto-injector shortage in Canada
In plain language
This notice is an information update about a shortage of EpiPen (0.3 mg) auto-injectors in Canada. The shortage is due to a manufacturing disruption. This product is used for life-threatening allergic reactions.
What to do
- Consult your healthcare professional for advice.
- Visit drugshortagescanada.ca for updates.
- Contact Pfizer directly for information.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
This notice is an information update about a shortage of EpiPen (0.3 mg) auto-injectors in Canada. The shortage is due to a manufacturing disruption. This product is used for life-threatening allergic reactions.
What should consumers do?
Consult your healthcare professional for advice. Visit drugshortagescanada.ca for updates. Contact Pfizer directly for information.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on January 18, 2018.
Is the EpiPen brand affected by this recall?
Yes, EpiPen products are affected by this recall. This notice is an information update about a shortage of EpiPen (0.3 mg) auto-injectors in Canada. The shortage is due to a manufacturing disruption. This product is used for life-threatening allergic reactions.